Metformin may lower cancer risk in people with Type 2 diabetes
Key points
- A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds.
- "Type 2 diabetes increases the risk for several types of cancer," said lead author Diego Espinoza-Peralta, MD, an endocrinologist with Mexico's National Institute of Medical Sciences and Nutrition (Instituto Nacional de Ciencias Medicas y Nutricion) in Mexico City.
- Espinoza-Peralta and his colleagues conducted a systematic review and meta-analysis, or combined statistical analysis, of reported studies that evaluated cancer risk in patients with Type 2 diabetes.
- The investigators found that the odds of getting any type of cancer was 0.62 times less - an estimated 38 percent relative risk reduction - with daily continuous use of metformin than for those with no exposure to metformin.
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
"Type 2 diabetes increases the risk for several types of cancer," said lead author Diego Espinoza-Peralta, MD, an endocrinologist with Mexico's National Institute of Medical Sciences and Nutrition (Instituto Nacional de Ciencias Medicas y Nutricion) in Mexico City. "Our findings suggest that the regular use of metformin - a low-cost medication - reduces this risk, compared with not taking metformin."
Espinoza-Peralta and his colleagues conducted a systematic review and meta-analysis, or combined statistical analysis, of reported studies that evaluated cancer risk in patients with Type 2 diabetes. They analyzed seven relevant studies that included more than 32,400 Type 2 diabetic patients who had no other known condition that increased their cancer risk.
The investigators found that the odds of getting any type of cancer was 0.62 times less - an estimated 38 percent relative risk reduction - with daily continuous use of metformin than for those with no exposure to metformin.
"This risk reduction with metformin use extended to certain types of cancers, specifically colon and breast cancer," Espinoza-Peralta said.
Colorectal cancer and breast cancer are among the cancers that studies have found to occur more often in people with Type 2 diabetes. There was no risk reduction, however, in pancreatic cancer, another type of cancer for which people with Type 2 diabetes are at increased risk, the authors reported.
Metformin, which is the standard recommended initial treatment of Type 2 diabetes, may protect against cancer because it regulates activity of an enzyme that suppresses cell growth, according to Espinoza-Peralta.
"There is growing evidence that metformin brings more benefits to diabetic patients beyond glucose control," he said.
###
Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsModerate drinking tied to lower diabetes risk
Middle aged women who eat a lot of refined carbs might offset their risk of type 2 diabetes by drinking a moderate amount of alcohol, a new study suggests. Following more than 80,000 women over 26 years, researchers…
26 November 2011
NewsRisk of contracting diabetes to increase in world of 7 billion people
World citizen number 7 billion is less likely to die from infectious diseases like measles or even AIDS, and more likely to contract diabetes or other non-communicable diseases (NCDs), as they are now the leading causes…
15 November 2011
NewsFiber-loving teens have lower heart, diabetes risks
Teenagers who eat a lot of fiber-rich foods, such as vegetables and whole grains, are less likely to have risk factors for diabetes and heart disease, a new study shows. But there was no link between those risk factors…
